Manulife (Manufacturers Life Insurance)’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,591
Closed -$306K 2962
2023
Q4
$306K Sell
10,591
-108
-1% -$2.89K ﹤0.01% 2401
2023
Q3
$286K Buy
10,699
+2,538
+31% +$86.6K ﹤0.01% 2396
2023
Q2
$302K Sell
8,161
-279
-3% -$9.72K ﹤0.01% 2357
2023
Q1
$263K Sell
8,440
-268
-3% -$8.63K ﹤0.01% 2384
2022
Q4
$259K Buy
8,708
+60
+0.7% +$2.15K ﹤0.01% 2400
2022
Q3
$330K Sell
8,648
-145
-2% -$7.27K ﹤0.01% 2245
2022
Q2
$479K Buy
8,793
+91
+1% +$5K ﹤0.01% 2083
2022
Q1
$543K Sell
8,702
-1,891
-18% -$125K ﹤0.01% 2155
2021
Q4
$1.07K Buy
10,593
+10
+0.1% +$879 ﹤0.01% 1787
2021
Q3
$952K Sell
10,583
-801
-7% -$72.8K ﹤0.01% 1876
2021
Q2
$1.05M Buy
11,384
+3,714
+48% +$297K ﹤0.01% 1970
2021
Q1
$741K Sell
7,670
-435
-5% -$44.9K ﹤0.01% 2050
2020
Q4
$422K Buy
8,105
+2,086
+35% +$87.2K ﹤0.01% 2301
2020
Q3
$241K Buy
+6,019
New +$188K ﹤0.01% 2450
2018
Q3
Sell
-180
Closed -$1K 3237
2018
Q2
$1K Hold
180
﹤0.01% 4248
2018
Q1
$1K Hold
180
﹤0.01% 4273
2017
Q4
$1K Hold
180
﹤0.01% 4267
2017
Q3
$1K Buy
180
+88
+96% +$506 ﹤0.01% 4162
2017
Q2
$1K Sell
92
-25
-21% -$202 ﹤0.01% 4211
2017
Q1
$1K Hold
117
﹤0.01% 4039
2016
Q4
$1K Buy
+117
New +$1.1K ﹤0.01% 4187

Other funds holding FLGT

Manulife (Manufacturers Life Insurance)'s FLGT Position: Q1 2024 in Review

Manulife (Manufacturers Life Insurance) sold out of Fulgent Genetics (FLGT) in Q1 2024, closing a stake of 10,591 shares — an estimated $306K sold.

Manulife (Manufacturers Life Insurance) first reported a position in FLGT in Q4 2016 and held it in 21 quarters. The position peaked at $1.05M in Q2 2021. 180 funds tracked by Wall St. Rank hold FLGT as of Q1 2024.

  • Manulife (Manufacturers Life Insurance) reported no remaining Fulgent Genetics position as of Q1 2024 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 10,591 Fulgent Genetics shares in Q1 2024, an estimated $306K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Fulgent Genetics in Q4 2016 and held it in 21 quarters.
  • Manulife (Manufacturers Life Insurance)'s Fulgent Genetics position peaked at $1.05M in Q2 2021.
  • 180 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2024.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2024, filed 14 May 2024.